IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX), developer of minimally invasive treatments for aortic disorders, announces the appointment of Daniel Hawkins (42) to the newly created position of Vice President of Global Marketing, effective immediately. Mr. Hawkins brings more than 15 years of marketing management and business development experience in the medical device and biotechnology industries.
